Skip to main content
Journal cover image

Multi-institutional Care in Clinical Stage II and III Esophageal Cancer.

Publication ,  Journal Article
Rhodin, KE; Raman, V; Jensen, CW; Kang, L; Nussbaum, DP; Tong, BC; Blazer, DG; D'Amico, TA
Published in: Ann Thorac Surg
February 2023

BACKGROUND: Management of clinical stage II or III esophageal cancer requires multidisciplinary care. Multi-institutional care has been associated with worse survival in other malignant diseases. This study aimed to determine the impact of multi-institutional care on survival in patients with stage II or III esophageal cancer. METHODS: The 2004 to 2016 National Cancer Database was queried for patients with clinical stage II or III esophageal cancer who received neoadjuvant chemotherapy with or without radiation therapy followed by surgical resection. Patients were stratified into 2 groups: multi-institutional or single-institution care. Survival between groups was compared using Kaplan-Meier and multivariable Cox proportional hazards methods. Multivariable logistic regression was performed to identify factors associated with multi-institutional care. RESULTS: Overall, 11 399 patients met study criteria: 6569 (57.6%) received multi-institutional care and 4,830 (42.4%) received care at a single institution. In a multivariable analysis, factors associated with multi-institutional care were later year of diagnosis, greater distance from treating facility, residence in an urban or rural setting (vs metro), and residence in states without Medicaid expansion. Care at a single institution was associated with Black race, lack of insurance, and treatment at higher-volume or academic centers. Despite these differences, patients who received multi-institutional care had survival comparable to that in patients who received care at a single institution (HR, 0.97; 95% CI, 0.92-1.03; P = .30). CONCLUSIONS: In this National Cancer Database analysis, multi-institutional care was not associated with inferior overall survival. As complex cancer care becomes more regionalized, patients may consider receiving part of their cancer care closer to home, whereas traveling to surgical centers of excellence should be encouraged.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

February 2023

Volume

115

Issue

2

Start / End Page

370 / 377

Location

Netherlands

Related Subject Headings

  • United States
  • Retrospective Studies
  • Respiratory System
  • Proportional Hazards Models
  • Neoplasm Staging
  • Neoadjuvant Therapy
  • Kaplan-Meier Estimate
  • Humans
  • Esophageal Neoplasms
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rhodin, K. E., Raman, V., Jensen, C. W., Kang, L., Nussbaum, D. P., Tong, B. C., … D’Amico, T. A. (2023). Multi-institutional Care in Clinical Stage II and III Esophageal Cancer. Ann Thorac Surg, 115(2), 370–377. https://doi.org/10.1016/j.athoracsur.2022.06.049
Rhodin, Kristen E., Vignesh Raman, Christopher W. Jensen, Lillian Kang, Daniel P. Nussbaum, Betty C. Tong, Dan G. Blazer, and Thomas A. D’Amico. “Multi-institutional Care in Clinical Stage II and III Esophageal Cancer.Ann Thorac Surg 115, no. 2 (February 2023): 370–77. https://doi.org/10.1016/j.athoracsur.2022.06.049.
Rhodin KE, Raman V, Jensen CW, Kang L, Nussbaum DP, Tong BC, et al. Multi-institutional Care in Clinical Stage II and III Esophageal Cancer. Ann Thorac Surg. 2023 Feb;115(2):370–7.
Rhodin, Kristen E., et al. “Multi-institutional Care in Clinical Stage II and III Esophageal Cancer.Ann Thorac Surg, vol. 115, no. 2, Feb. 2023, pp. 370–77. Pubmed, doi:10.1016/j.athoracsur.2022.06.049.
Rhodin KE, Raman V, Jensen CW, Kang L, Nussbaum DP, Tong BC, Blazer DG, D’Amico TA. Multi-institutional Care in Clinical Stage II and III Esophageal Cancer. Ann Thorac Surg. 2023 Feb;115(2):370–377.
Journal cover image

Published In

Ann Thorac Surg

DOI

EISSN

1552-6259

Publication Date

February 2023

Volume

115

Issue

2

Start / End Page

370 / 377

Location

Netherlands

Related Subject Headings

  • United States
  • Retrospective Studies
  • Respiratory System
  • Proportional Hazards Models
  • Neoplasm Staging
  • Neoadjuvant Therapy
  • Kaplan-Meier Estimate
  • Humans
  • Esophageal Neoplasms
  • 3202 Clinical sciences